FILTER
FILTERED INTERVIEW RESULTS
Manni Kantipudi & Ramesh Subramanian
CHIEF EXECUTIVE OFFICER (CEO) AND CHIEF COMMERCIAL OFFICER (CCO), ARAGEN LIFE SCIENCES
Aragen Life Sciences explains how its expansion in both India and US can benefit drug discovery companies.
Robert Bloder
CHIEF BUSINESS OFFICER, ASCENDIA PHARMACEUTICALS
"We were excited to secure equity investment from Signet Healthcare Partners and have since almost doubled in size in both our capacity and talent pool."
Will Lewis
CHAIRMAN & CEO, INSMED
"Insmed developed a drug-device combination that became the first approved therapy to treat patients with a refractory form of a rare and serious lung infection."
Anne Pritchett
SENIOR VICE PRESIDENT OF POLICY, RESEARCH AND MEMBERSHIP, PHRMA
"Our organization advocates for public policies that encourage the research and development and manufacturing of new medicines that allow patients to lead longer, healthier, and more productive lives."
Tom Sellig
CEO, ADARE PHARMA SOLUTIONS
"Our reputation is based on how we deploy technologies to solve complex formulation challenges."
Mark Jara
PRINCIPAL AND MANAGING DIRECTOR, RXS
"Tele-health tactics gained momentum and our clients made their pivot, like other industries, to fully remote operations. RxS, with our technology-forward approach, was prepared for the shift."
Candice Long
PRESIDENT – US INFECTIOUS DISEASES & VACCINES, JANSSEN PHARMACEUTICALS
"In vaccines, we are progressing late-stage programs of break-through vaccines against diseases where vaccines are not currently available, such as RSV and multidrug resistant bacterial infections, including ExPEC and Staphylococcus aureus."
Joe Panetta
PRESIDENT & CEO, BIOCOM CALIFORNIA
"We experienced explosive growth across the state and consequently adopted a new name: Biocom California."
John Pennett
PARTNER-IN-CHARGE OF THE NATIONAL TECHNOLOGY AND LIFE SCIENCES GROUP, EISNERAMPER
EisnerAmper speaks about the investment climate for pharma entrepreneurs.
Swapan Bhattacharya
MANAGING DIRECTOR, TCG LIFESCIENCES
TCG Lifesciences explains its discovery engine aimed to build out a large portfolio of new chemical entities that can one day become marketed drugs
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Latin America Petrochemicals and Chemicals 2024 - Digital Interactive
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
